DUBLIN, Sept. 6, 2023 /PRNewswire/ — In light of the recent European Medicines Agency’s safety committee recommendation against the use of topiramate-containing medicines in pregnant women, the importance of rigorous pharmacovigilance practices has never been more evident. The…